Monday, August 22, 2016
Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research
The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection.
Wednesday, August 17, 2016
School of Medicine Graduate Students are Turning a Cancer Test into a Business
Ph.D. students Camilo Vanegas and Elizabeth Weingarter were winners in a competition called the Nanotechnology Startup Challenge in Cancer. Now they are taking a device that detects chronic myeloid leukemia (CML) to market.
Monday, August 08, 2016
University of Maryland Mourns the Passing of Hamish Osborne
University of Maryland School of Medicine faculty and Medical System staff mourn the passing of Hamish S. Osborne. His vision and financial support led to the creation of the Program in Lung Healing, and an endowed professorship in his name.
Thursday, August 04, 2016
UM SOM is Center Stage in Testing National Institutes of Health Zika Vaccine
UM SOM'S Center for Vaccine Development, tapped previously for Ebola vaccine, now steps up to help develop first Zika vaccine.
Tuesday, July 26, 2016
UM SOM Researchers Shed Light on How Neurons Exchange Neurotransmitters
For more than a century, neuroscientists have known that nerve cells talk to one another across the small gaps between them, a process known as synaptic transmission. But the details of how this crucial aspect of brain function occurs have remained elusive. Now, new research has for the first time elucidated details about the architecture that allows brain cells to communicate. The paper was published today in the journal Nature.
Monday, July 25, 2016
UM SOM Launches Unprecedented Initiative to Recruit Scores of Top Scientists
University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, today announced the launch of a bold, new and unprecedented faculty recruitment initiative, Special Trans-Disciplinary Recruitment Award Program (STRAP), designed to attract top scientists to the School, and to significantly catalyze UM SOM’s focus on accelerating discoveries, cures and therapeutics for the most serious diseases that cause morbidity, mortality and disability.
Friday, July 22, 2016
UMSOM Researchers Provide New Insight into Deadly Fungal Infections
A new study by scientists at the University of Maryland School of Medicine has provided new, crucial insights into how little-known but life threatening fungal infections cause damage in the body. The study was published today in the journal Nature Communication. The researchers delineated several key aspects of the fungus that might help researchers develop treatments.
Tuesday, July 19, 2016
New Surgical Tool for Mitral Valve Repair Demonstrates Success in First Human Clinical Study
Researchers investigating a novel device to repair the mitral heart valve report 100 percent procedural success in a safety and performance study, the first such study done in humans. The image-guided device, based on technology developed at the University of Maryland School of Medicine, is deployed through a tiny opening in a beating heart, avoids open-heart surgery, automates a key part of the valve repair process, simplifies the procedure and reduces operating room time. The research is published in the journal Circulation.
Thursday, July 14, 2016
Dr. Charles B. Simone, II Appointed Medical Director of the Maryland Proton Treatment Center
William F. Regine, MD, FACR, FACRO, the Isadore & Fannie Foxman Schneider Endowed Chairman and Professor of Radiation Oncology at the University of Maryland School of Medicine (UM SOM) and the Executive Director of the Maryland Proton Treatment Center (MPTC), along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Charles B. Simone, II, MD, a nationally-recognized expert in proton therapy at the University of Pennsylvania, has been named the new Medical Director of the MPTC. Dr. Simone will also be appointed Associate Professor in the UM SOM Department of Radiation Oncology and will begin in his new position in November 2016.
Wednesday, July 06, 2016
UMSOM Begins Malaria Vaccine Trial in Burkina Faso
Malaria is one of the world’s deadliest diseases: it infects hundreds of millions of people every year, and kills about half a million, most of them under five years of age.